Get started
Author

Jessalyn J. Baljon

Observed name: Jessalyn J Baljon
ORCID: 0000-0002-6524-3869
Observed ORCID: 0000-0002-6524-3869
OpenAlex ID: A5011574498
Microporous methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel for bone tissue engineering
2019 · Zhong-Kai Cui, Soyon Kim, et al. · Nature Communications · 432
PDF
Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines
2020 · Daniel Shae, Jessalyn J. Baljon, et al. · ACS Nano · 160
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration
2020 · Mohamed Wehbe, Lihong Wang-Bishop, et al. · Journal of Controlled Release · 127
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
2023 · Lihong Wang-Bishop, Blaise R. Kimmel, et al. · Science Immunology · 126
PDF
A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists
2024 · Jessalyn J. Baljon, Alexander J. Kwiatkowski, et al. · ACS Nano · 121
PDF
Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
2018 · Feng Qiu, Kyle W. Becker, et al. · Biomaterials · 86
Design and Characterization of a Therapeutic Non-phospholipid Liposomal Nanocarrier with Osteoinductive Characteristics To Promote Bone Formation
2017 · Zhong-Kai Cui, Soyon Kim, et al. · ACS Nano · 60
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation
2022 · Jessalyn J Baljon, John T Wilson · Current Opinion in Immunology · 47
Simultaneous delivery of hydrophobic small molecules and siRNA using Sterosomes to direct mesenchymal stem cell differentiation for bone repair
2017 · Zhong-Kai Cui, Justin A. Sun, et al. · Acta Biomaterialia · 47
A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA
2022 · Carcia S. Carson, Kyle W. Becker, et al. · Journal of Controlled Release · 36
At the bench: Engineering the next generation of cancer vaccines
2019 · Daniel Shae, Jessalyn J Baljon, et al. · Journal of Leukocyte Biology · 32
PDF
The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome
2019 · Jessalyn J. Baljon, Aamina Dandy, et al. · Biomaterials Science · 24
Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing
2023 · Hayden M. Pagendarm, Payton T. Stone, et al. · Nanoscale · 16
PDF
Correction: The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome
2019 · Jessalyn J. Baljon, Aamina Dandy, et al. · Biomaterials Science · 13
PDF
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al. · Cancer Research Communications · 5
Data from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al. · 1
Flash nanoprecipitation for the production of endosomolytic polymersomes for cytosolic drug delivery
2021 · Hayden M Pagendarm, Payton T Stone, et al. · ChemRxiv · 1
PDF
Figure S7 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
Figure S8 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
Figure S6 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
PDF
Figure S2 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
PDF
Figure S4 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
Figure S3 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
Figure S5 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
Figure S1 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
2023 · David C. Florian, Natalie E. Bennett, et al.
Works count: 34
Citation count: 1,334
H-index: 13
I10-index: 14
Year
Topic
Type